Our Pune Pilot Study Is Now a Preprint on medRxiv
The AI-NETRA evaluation in Pune district is now available as a preprint on medRxiv. The paper is titled Geospatial AI targeting of tuberculosis active case finding in Pune, India: a quasi-experimental evaluation. It was posted on 12 November 2026 by authors from Froncort.AI, the State TB Office of Maharashtra, and FIND. Read the paper on medRxiv.
A preprint is a complete scientific paper shared publicly before peer review. Posting it now lets TB programmes, researchers, and funders examine the methods and data, and comment on them, while formal review continues.
What the paper adds to the pilot report
In July we published the full Pune Pilot Study report. The preprint focuses on the field comparison and presents it in standard scientific form. It sets out a pre-specified primary endpoint, exact statistical tests with confidence intervals, sensitivity analyses, and a detailed account of the study's limitations.
How the study was run
The study took place in four TB units in Pune district: Bhor and Shirur, which are rural, and Haveli PMC and Haveli PCMC, which are urban. Over two weeks in April and May 2026, field teams used AI-NETRA plans to screen households in the neighbourhoods the model ranked as highest risk. Everyone with symptoms was referred for a molecular test.
The results were compared with the routine district screening campaign carried out in the same four units in December 2024 and January 2025. The main measure was the number of laboratory-confirmed pulmonary TB cases found for each person screened.
What it found
AI-guided teams visited 17,817 households, screened 66,095 people, and confirmed 10 cases of pulmonary TB. The standard campaign screened 177,322 people and confirmed 9.
Confirmed cases per person screened were about three times higher with AI-guided targeting, a rate ratio of 2.98 (95% CI 1.09 to 8.29).
The number of people screened to find one confirmed case fell from 19,702 to 6,610, about two-thirds fewer.
The cost per confirmed case fell from Rs 27.6 lakh to Rs 9.3 lakh, 66 percent lower.
Of 326 people with presumptive TB in the AI-guided arm, 325 were tested.
What frontline workers said
The paper also reports 16 group discussions with 100 frontline workers and a survey of 101 ASHAs after the campaign. Fifteen of the 16 groups rated the AI-NETRA plan better than paper and said they would recommend it. In the survey, 96 percent of ASHAs said they found the same presumptive cases while screening fewer people, 94 percent found navigation easy, and 92 percent said their workload was lighter.
Workers also told us what did not work. Only 3 of the 16 groups agreed with the screening target shown in each plan. Turn-by-turn navigation failed for most workers in one dense urban group. Sixty-two percent of ASHAs still met stigma in the community. These findings are shaping the next version of the tool.
What the paper does not claim
The paper is clear about the limits of this evidence.
Total detection did not differ. Counting all forms of TB, the AI-guided arm found 15 cases and the standard campaign found 32, a rate ratio of 1.26 (95% CI 0.63 to 2.39). The standard campaign had a mobile chest X-ray van. The AI-guided sweep did not.
The two campaigns did not run at the same time, and they used different testing. The AI-guided arm sent everyone with symptoms for a molecular test. The standard arm relied mainly on sputum microscopy.
The numbers are small. If any single AI-arm case is removed, the rate ratio becomes 2.68 (95% CI 0.94 to 7.63) and is no longer statistically significant.
The study covers a single district.
The authors describe the main result as real but fragile, and as hypothesis-generating. The next step they recommend is a concurrent cluster-randomised or stepped-wedge trial, in which both approaches run side by side under the same conditions and case definitions.
Open methods and disclosures
The AI-NETRA case-finding model is open source under the Apache-2.0 licence on GitHub. The repository contains no patient data. The study was funded by Google.org, which had no role in its design, analysis, or the decision to publish. Froncort.AI developed AI-NETRA, and the paper sets out the authors' competing interests in full.
Read the paper
The full preprint, with methods, tables, and supplementary data, is available on medRxiv. The complete field report, including the diagnostic network planning work, is on the Pune Pilot Study page.